Tuesday, Sep 28, 2021
Focus on the big picture

China's Sinopharm plans annual capacity of 5 billion COVID-19 vaccine doses

CGTN, 31 Jul 2021
For more:

Sinopharm CNBG has just launched a new phase-3 production site for its COVID-19 vaccines in Chinese capital Beijing. The company says it now expects to increase annual vaccine production to 5 billion doses. In June, CGTN's reporter Liu Yang spoke to Wang Hui, general manager and director of CNBG's Beijing Institute of Biological Products. She talked about the significance of putting the phase-3 production site into operation, the allocation plan, vaccine's efficacy to the Delta variant and herd immunity in China.

Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
Related Articles